Syphilis

Coachella Concerned That People Have Sex, Says AHF

Retrieved on: 
Thursday, March 28, 2024
Entertainment, AIDS, Health, Infectious Diseases, Music, Events, Concerts, AIDS Healthcare Foundation, STD, Condom, Syphilis, URL, Sand, Coachella (festival), United, STI, Gonorrhea, CDC, Chlamydia, AHF, Multimedia, Advertising, Pharmaceutical industry

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    The Coachella-themed billboard went up Tuesday, March 26, 2024 and will remain up throughout April as Coachella spans two weekends: April 12-14 and April 19-21.
  • Do they really not know how people spend their time during festival weekends?” said Michael Weinstein, AHF president and cofounder.
  • California ranks 22 in reported cases of chlamydia, 18th in reported cases of gonorrhea, and 19th in cases of syphilis.
  • To learn more about AHF, visit us online at AIDShealth.org , find us on Facebook , follow us on Instagram , Twitter , and TikTok , and subscribe to our AHFter Hours podcast.

NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

Retrieved on: 
Thursday, March 21, 2024
Biotechnology, General Health, Other Health, Health, Medical Supplies, College, Growth, Thomas Jefferson University, OraSure Technologies, HIV, Business, University, COVID-19, Syphilis, Research, History, Humanities, MBA, OTC, POC, Chemical engineering, Multimedia, Lehigh University, FDA, University City Science Center, Population Services International, Management

NOWDiagnostics ( NOWDx ), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-class technology and platforms, today announced the appointment of Dr. Stephen S. Tang, Ph.D., MBA, as the chairman of the company’s board of directors.

Key Points: 
  • NOWDiagnostics ( NOWDx ), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-class technology and platforms, today announced the appointment of Dr. Stephen S. Tang, Ph.D., MBA, as the chairman of the company’s board of directors.
  • View the full release here: https://www.businesswire.com/news/home/20240321747977/en/
    NOWDiagnostics (NOWDx) Welcomes Dr. Stephen S. Tang as Chairman of the Board (Photo: Business Wire)
    Dr. Tang is a longtime veteran of the medical diagnostic industry.
  • He led OraSure Technologies, Inc. (NASDAQ: OSUR ), a pioneer and global leader in rapid at-home tests for HIV and COVID-19, for ten years as president and CEO, chairman of the board of directors, and chairman of the compensation committee.
  • “I am delighted and enthusiastic about joining the NOWDx team as their chairman of the board,” said Dr. Tang.

Dr. Jody Douglas Berry Joins NOWDiagnostics as Chief Scientific Officer

Retrieved on: 
Thursday, March 14, 2024
Infectious Diseases, Biotechnology, Health, COVID-19, De novo, DPA, Growth, RBD, OraSure Technologies, Syphilis, Cangene, Research, Public Health Agency, HHS, SARS-CoV-2, National Microbiology Laboratory, Infection, Congenital syphilis, Therapy, CSO, FDA, Government, Pharmaceutical industry

NOWDiagnostics (NOWDx) today announced the appointment of Jody Douglas Berry, Ph.D. as chief scientific officer (CSO).

Key Points: 
  • NOWDiagnostics (NOWDx) today announced the appointment of Jody Douglas Berry, Ph.D. as chief scientific officer (CSO).
  • Dr. Berry, a distinguished scientific leader with over two decades of experience in infectious diseases, brings a wealth of expertise in diagnostics and therapeutics to the role.
  • A recognized international expert in immunoassay development, antibody technology, and infectious diseases, Dr. Berry has over two decades of commercial, government and academic experience.
  • Dr. Berry earned international recognition for his contributions to immunoassay development, antibody technology, and protein design.

Diagnostics Direct, LLC Announces Formation of a Medical Advisory Board

Retrieved on: 
Wednesday, March 13, 2024
Diagnosis, Attention, Advisory board, Public health, Entrepreneurship, Syphilis, Patient, Public, USC, STI, MPH, Point-of-care testing, FDA, Pharmaceutical industry

STONE HARBOR, N.J., March 13, 2024 /PRNewswire/ -- Diagnostics Direct LLC, a leading provider of diagnostic testing solutions, is proud to announce the formation of its distinguished Medical Advisory Board.

Key Points: 
  • STONE HARBOR, N.J., March 13, 2024 /PRNewswire/ -- Diagnostics Direct LLC, a leading provider of diagnostic testing solutions, is proud to announce the formation of its distinguished Medical Advisory Board.
  • Board members have expressed their enthusiasm for the impact they can have on the syphilis epidemic by working with Diagnostics Direct:
    Dr. Jeffrey Klausner remarked, "I am pleased to lead the Diagnostics Direct Medical Advisory Board.
  • Dr. Leandro Mena shared, "I am thrilled to join the Diagnostics Direct Medical Advisory Board, where our shared dedication to revolutionizing point-of-care testing and enhancing syphilis diagnostics is key.
  • The formation of the Medical Advisory Board by Diagnostics Direct signifies a major step forward in combating the spread of syphilis through innovative, accessible testing solutions.

Sexual Health Pioneer, VerifiedMD, Introduces First STD Verification Badge

Retrieved on: 
Tuesday, March 5, 2024
Infection, Gonorrhea, STD, Syphilis, Partner (business rank), HIV, Risk, Partnership

NEW YORK, March 5, 2024 /PRNewswire/ -- VerifiedMD, a leading innovator in sexual health services, has launched the industry's first verification badge. The VerifiedMD badge empowers individuals to take ownership of their sexual health through a discreet, yet tangible symbol to show they are within normal limits on the day of STD testing.

Key Points: 
  • NEW YORK, March 5, 2024 /PRNewswire/ -- VerifiedMD , a leading innovator in sexual health services, has launched the industry's first verification badge.
  • The VerifiedMD badge empowers individuals to take ownership of their sexual health through a discreet, yet tangible symbol to show they are within normal limits on the day of STD testing.
  • To be eligible for the VerifiedMD badge, VerifiedMD provides a one-of-a-kind concierge testing service that allows for convenient, professional testing of six common STDs.
  • The VerifiedMD badge enables transparent confirmation of sexual health status without the associated emotions.

Government of Canada releases 2024-2030 Action Plan on Sexually Transmitted and Blood-Borne Infections

Retrieved on: 
Tuesday, February 27, 2024
Inhalation, Violence, Infection, Syphilis, CIHR, AIDS, Federation, Government, Action plan, Metis, Ectopic pregnancy, Viral hepatitis, First Nations, Science, Risk, Housing, Public, Research, Infertility, Cancer, Birth control

OTTAWA, ON, Feb. 27, 2024 /CNW/ - Sexually transmitted and blood-borne infections (STBBI) are largely preventable, treatable, and in many cases curable.

Key Points: 
  • OTTAWA, ON, Feb. 27, 2024 /CNW/ - Sexually transmitted and blood-borne infections (STBBI) are largely preventable, treatable, and in many cases curable.
  • However, rates of sexually transmitted infections in Canada have increased over the last decade—gonorrhea rates have doubled since 2012, and syphilis rates are five times what they were.
  • That is why today, the Honourable Mark Holland, Minister of Health, launched the Government of Canada's sexually transmitted and blood-borne infections (STBBI) action plan 2024-2030 and announced $2.45 million in funding to address STBBI in Canada.
  • The Action Plan will continue to work towards reducing STBBI related stigma, to prevent new and reoccurring infections and connect people to testing, prevention, treatment and care."

Government of Canada supports community-based projects addressing HIV, Hepatitis C, and other sexually transmitted and blood-borne infections

Retrieved on: 
Friday, February 23, 2024
Parliament, HIV/AIDS, Infection, Syphilis, Investment, Quality of life, Harm reduction, Government, Hepatitis, Address, CAF, Risk, Public Health Agency, PHAC, Stigma, HRF, Chlamydia, Knowledge, Hepatitis C, Gonorrhea, Mental health, HIV, Public

However, these infections remain a significant public health concern in Canada, especially among Indigenous, 2SLGBTQ+, and other equity-deserving communities.

Key Points: 
  • However, these infections remain a significant public health concern in Canada, especially among Indigenous, 2SLGBTQ+, and other equity-deserving communities.
  • Today's funding includes more than $12 million through the CAF, which will support 15 community-based interventions to address HIV, hepatitis C and other STBBI.
  • In 2022, the Government of Canada invested $106.4 million to help address STBBI across Canada.
  • Through the HIV and Hepatitis C Community Action Fund, the Public Health Agency of Canada (PHAC) invests $26.4 million annually to support time-limited projects (up to 5 years) across Canada to address HIV, hepatitis C and other sexually transmitted infections (e.g., chlamydia, gonorrhea, syphilis).

Syphilis Soars: AHF Urges Congress to Boost Prevention Funding

Retrieved on: 
Tuesday, January 30, 2024
Men, LGBTQ+, Pharmaceutical, Consumer, Infectious Diseases, Public Policy, Other Policy Issues, Biotechnology, Women, AIDS, Congressional News, Views, Health, Government, United States Congress, Public, Associate, AHF, Congenital syphilis, Advocacy, AIDS Healthcare Foundation, Congress, STI, Syphilis, Infection

With alarmingly high rates of preventable syphilis and congenital syphilis skyrocketing to nearly 20% higher than in 2023, AIDS Healthcare Foundation (AHF) urges U.S. Congress to reverse proposed cuts and increase funding for sexually transmitted infection prevention programs and improved access to testing and treatment.

Key Points: 
  • With alarmingly high rates of preventable syphilis and congenital syphilis skyrocketing to nearly 20% higher than in 2023, AIDS Healthcare Foundation (AHF) urges U.S. Congress to reverse proposed cuts and increase funding for sexually transmitted infection prevention programs and improved access to testing and treatment.
  • “Sexually transmitted infections, including syphilis, are at an all-time high for the sixth consecutive year, yet budgets for these programs are being cut every year,” said Lauren Natoli, Associate Director of Research and Advocacy for AHF’s Public Health Division.
  • “We cannot hope to reverse the tide of STIs without renewed investment and attention to public health efforts.
  • It is time to reinvest in public health and sex education.”

Sagebrush Partners with Southern Nevada Health District to Provide Syphilis Treatment

Retrieved on: 
Wednesday, January 17, 2024
Sagebrush, Risk, Syphilis, Congenital syphilis, Patient, Infection, Prenatal care, Health, Pharmaceutical industry

Las Vegas, Nevada--(Newsfile Corp. - January 17, 2024) - As the United States struggles with a congenital syphilis epidemic and a shortage of the treatment medication Bicillin® L-A , Sagebrush Health ("Sagebrush") has announced that it will be assisting patients who tested positive for the sexually transmitted infection and are referred by the Southern Nevada Health District.

Key Points: 
  • Las Vegas, Nevada--(Newsfile Corp. - January 17, 2024) - As the United States struggles with a congenital syphilis epidemic and a shortage of the treatment medication Bicillin® L-A , Sagebrush Health ("Sagebrush") has announced that it will be assisting patients who tested positive for the sexually transmitted infection and are referred by the Southern Nevada Health District.
  • In particular, Nevada ranked 5th for primary and secondary syphilis and ranked 9th for congenital syphilis rates in 2021.
  • Concerned by this issue, the leadership at Sagebrush has partnered with the Southern Nevada Health District to provide treatment for patients with syphilis.
  • With the goal of lowering congenital syphilis rates, Sagebrush will also be providing screening for people who are at increased risk for syphilis.

Global IVD Quality Control Industry Report 2023-2030: Third-Party Quality Controls in High Demand, Fueling Market Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 17, 2024
Health, Biotechnology, Conditional sentence, Hepatitis, Hospital, IVD, Syphilis, Gonorrhea, Infection, WHO, Quality control, Vertically transmitted infection, Fungal infection, STI, Birth, POC, Trichomoniasis, Diagnosis, Prevalence, Growth, Pharmaceutical industry

The "IVD Quality Control Market by Offering, Application, and End User - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "IVD Quality Control Market by Offering, Application, and End User - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The IVD quality control market is expected to reach $2.19 billion by 2030, at a CAGR of 4.3% from 2023 to 2030.
  • Among the offering, in 2023, the quality control products segment is estimated to account for the largest share of the IVD quality control market.
  • Among the application, in 2023, the infectious diseases segment is estimated to account for the largest share of the IVD quality control market.